{"id":172545,"date":"2010-01-12T17:25:30","date_gmt":"2010-01-12T22:25:30","guid":{"rendered":"tag:typepad.com,2003:post-6a00d8341c89dd53ef012876cd24de970c"},"modified":"2010-01-13T07:42:00","modified_gmt":"2010-01-13T12:42:00","slug":"fda-introduces-a-new-web-site-intended-to-give-the-public-more-insight-about-agencys-work","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/172545","title":{"rendered":"FDA Introduces A New Web Site Intended To Give The Public More Insight About Agency&#8217;s Work"},"content":{"rendered":"<div xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n<p><strong><span style=\"FONT-SIZE: 14px; FONT-FAMILY: \"><span style=\"FONT-SIZE: 15px; FONT-FAMILY: \"><span style=\"FONT-SIZE: 16px; FONT-FAMILY: \">FDA Basics: \u00a0Site Seeks To Present Information To Consumers And Patients In Useful And User-Friendly Format<\/span><\/span><\/span><\/strong><\/p>\n<p><strong><span style=\"FONT-SIZE: 14px; FONT-FAMILY: \"><span style=\"FONT-SIZE: 15px; FONT-FAMILY: \"><span style=\"FONT-SIZE: 16px; FONT-FAMILY: \"><\/p>\n<p><span style=\"FONT-SIZE: 16px; FONT-FAMILY: Verdana\"><span style=\"FONT-SIZE: 16px; FONT-FAMILY: Verdana\"><span style=\"FONT-SIZE: 16px; FONT-FAMILY: Verdana\"><span style=\"FONT-SIZE: 16px; FONT-FAMILY: Verdana\"><font size=\"2\"><strong>(Posted by Tom Lamb at <a href=\"http:\/\/www.drug-injury.com\/\" ><span style=\"COLOR: #003366\"><font size=\"2\"><strong>DrugInjuryWatch.com<\/strong><\/font><\/span><\/a><font size=\"2\"><strong>)<\/strong><\/font><\/strong><\/font><\/span><\/span><\/span><\/span><\/p>\n<p><\/span><\/span><\/span><\/strong><\/p>\n<p>On January 12, 2009 Dr. Joshua Sharfstein, Principal Deputy Commissioner of the FDA, introduced <a href=\"http:\/\/www.fda.gov\/AboutFDA\/Basics\/default.htm\" >FDA Basics<\/a>, which is a new Web resource intended to answer questions from consumers and patients as well as to discuss other important public health topics in a useful and user-friendly format.<\/p>\n<p>Structurally, <a href=\"http:\/\/www.fda.gov\/AboutFDA\/Basics\/default.htm\" >FDA Basics<\/a> consists of the following sections:<\/p>\n<ul>\n<li>FDA Fundamentals\n<li>Animal &amp; Veterinary\n<li>Cosmetics &amp; Color Additives\n<li>Dietary Supplements\n<li>Drugs\n<li>Food\n<li>Medical Devices\n<li>Radiation-Emitting Products\n<li>Tobacco Products\n<li>Vaccines, Blood, and Biologics <\/li>\n<\/li>\n<\/li>\n<\/li>\n<\/li>\n<\/li>\n<\/li>\n<\/li>\n<\/li>\n<\/li>\n<\/ul>\n<p dir=\"ltr\" style=\"MARGIN-RIGHT: 0px\">Of particular interest to us is <a href=\"http:\/\/www.fda.gov\/AboutFDA\/Basics\/ucm192696.htm\" >the Drugs section of FDA Basics<\/a>.\u00a0 It includes the three sets of questions set forth below, with each question linked to responsive information:<\/p>\n<blockquote dir=\"ltr\">\n<p dir=\"ltr\" style=\"MARGIN-RIGHT: 0px\"><strong><span>Drug Approval<br \/><\/span><\/strong><br \/>What is the approval process for a new prescription drug?\u00a0\u00a0<\/p>\n<p>What are over-the-counter (OTC) drugs and how are they approved?\u00a0 <\/p>\n<p>What are generic drugs and how are they approved?\u00a0 <\/p>\n<p>Are generic drugs the same as brand name drugs?\u00a0 <\/p>\n<p>How do I find out if a drug is approved? Is there a Web site I can go to?\u00a0 <\/p>\n<p>How can I get access to a drug that is in testing but has not yet been approved?\u00a0 <\/p>\n<p>Does FDA approve the color additives used in drugs? If so, how does FDA determine their safety?\u00a0 <\/p>\n<p><strong>Information About Drugs<\/strong><\/p>\n<p>What are the possible side effects of a drug and where can I find the most current information about my drug?\u00a0 <\/p>\n<p>Why do some drug labels get changed so often ?\u00a0 <\/p>\n<p>Does FDA approve the information given out by pharmacies when I pick up my medicine? <\/p>\n<p>Can FDA ban direct-to-consumer drug advertising?<\/p>\n<p><strong>Safety<\/strong><\/p>\n<p>How does FDA decide when a drug is not safe enough to stay on the market?\u00a0 <\/p>\n<p>What is a Warning Letter?\u00a0 <\/p>\n<p>Why isn\u2019t a drug taken off the market when a manufacturer gets a Warning Letter?\u00a0 <\/p>\n<p>How does FDA oversee domestic and foreign drug manufacturing?\u00a0 <\/p>\n<\/blockquote>\n<p dir=\"ltr\">During a January 12 webinar for bloggers interested in health-related topics, the FDA&#8217;s Dr. Sharfstein emphasized that this <a href=\"http:\/\/www.fda.gov\/AboutFDA\/Basics\/default.htm\" >FDA Basics<\/a> site was still in the development stage and he encouraged the public to submit comments or suggestions that might help the agency improve the site going forward.<\/p>\n<p>______________________________________________________________________________<\/p>\n<p><a href=\"http:\/\/www.druginjurylaw.com\/\" ><strong><span style=\"FONT-SIZE: 14px; FONT-FAMILY: \"><font color=\"#810081\">DrugInjuryLaw.com<\/font><\/span><\/strong><\/a>: <span style=\"COLOR: #ff0000; FONT-FAMILY: \"><span style=\"COLOR: #80c0ff; FONT-FAMILY: \"><span style=\"COLOR: #800000; FONT-FAMILY: \"><span style=\"COLOR: #302449; FONT-FAMILY: \"><strong>Legal Information And News About Prescription Drug Side Effects<\/strong><\/span><\/span><\/span><\/span><\/p>\n<p><script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F10%2Fdrug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A\/\/www.drug-injury.com\/druginjurycom\/2009\/10\/drug-safety-experts-urge-fda-to-make-drug-safety-info-more-accessible-to-patients--matthew-perrone--ap-business-writer--419.html&amp;showad=true\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F11%2Fbyetta-exenatide-kidney-function-renal-failure-fda-dear-doctor-label-change-october-2009.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F11%2Faranesp-darbepoetin-alfa-associated-with-heightened-stroke-risk-amgen-treat-study-nejm-october.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F11%2Fanemia-drugs-aranesp-procrit-blood-clots-study-esas-thromboembolism-dvt-pe-stroke.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F11%2Fconsumers-unions-safe-patient-project-forum-webcast-to-err-is-human-to-delay-is-deadly.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F11%2Fdrug-industry-document-archive-dida-ucsf-november-2009-additions.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F11%2Fyaz-drsp-safety-inas-oc-study-venous-thrombosis-pulmonary-embolism-myocardial-infarction-cerebrovascular-accidents.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F11%2Fmeridia-stroke-heart-attack-cardiac-death-fda-sibutramine-early-communication.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F12%2Ffosamax-onj-side-effect-osteonecrosis-jaw-bisphosphonates-medical-journal-articles-november-2009.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F12%2Fpulmonary-embolism-drug-reactions-yaz-yasmin-ocella-nuvaring-ortho-evra-diagnostic-errors.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F12%2Fvoltaren-diclofenac-linked-liver-failure-drug-induced-liver-injury-december-2009-fda.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F12%2Ffosamax-femur-fractures-femoral-stress-bisphosphonates-drug-injury.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F12%2Fdigitek-federal-court-mdl-judge-sets-joint-daubert-hearing-nj-pa-tx-nj-consolidations.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F12%2Fzetia-vytorin-cancer-side-effect-safety-study-update-fda-december-2009.html\" type=\"text\/javascript\"><\/script><br \/>\n<script src=\"http:\/\/feeds.feedburner.com\/~s\/drug-injury-watch?i=http%3A%2F%2Fwww.drug-injury.com%2Fdruginjurycom%2F2009%2F12%2Ffda-gao-report-december-2009-drug-safety-monitoring-agency-changes.html\" type=\"text\/javascript\"><\/script><\/div>\n<div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?a=Bm0PwSwqOsE:8hLUHoDJpeY:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?a=Bm0PwSwqOsE:8hLUHoDJpeY:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?i=Bm0PwSwqOsE:8hLUHoDJpeY:F7zBnMyn0Lo\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?a=Bm0PwSwqOsE:8hLUHoDJpeY:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?i=Bm0PwSwqOsE:8hLUHoDJpeY:V_sGLiPBpWU\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?a=Bm0PwSwqOsE:8hLUHoDJpeY:l6gmwiTKsz0\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?d=l6gmwiTKsz0\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?a=Bm0PwSwqOsE:8hLUHoDJpeY:gIN9vFwOqvQ\"><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~ff\/drug-injury-watch?i=Bm0PwSwqOsE:8hLUHoDJpeY:gIN9vFwOqvQ\" border=\"0\"><\/img><\/a>\n<\/div>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/drug-injury-watch\/~4\/Bm0PwSwqOsE\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FDA Basics: \u00a0Site Seeks To Present Information To Consumers And Patients In Useful And User-Friendly Format (Posted by Tom Lamb at DrugInjuryWatch.com) On January 12, 2009 Dr. Joshua Sharfstein, Principal Deputy Commissioner of the FDA, introduced FDA Basics, which is a new Web resource intended to answer questions from consumers and patients as well as [&hellip;]<\/p>\n","protected":false},"author":2827,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-172545","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/172545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/2827"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=172545"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/172545\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=172545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=172545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=172545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}